These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9637143)

  • 21. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.
    Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Ruutu M; Bill-Axelson A;
    Lancet Oncol; 2011 Sep; 12(9):891-9. PubMed ID: 21821474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Psychological impact of prostate cancer on patients receiving a 6-month androgen deprivation therapy].
    de la Taille A; Mardoyan S; Lafaye A
    Prog Urol; 2018 Jan; 28(1):32-38. PubMed ID: 29223415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer.
    Madalinska JB; Essink-Bot ML; de Koning HJ; Kirkels WJ; van der Maas PJ; Schröder FH
    J Clin Oncol; 2001 Mar; 19(6):1619-28. PubMed ID: 11250990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How does active surveillance for prostate cancer affect quality of life? A systematic review.
    Bellardita L; Valdagni R; van den Bergh R; Randsdorp H; Repetto C; Venderbos LD; Lane JA; Korfage IJ
    Eur Urol; 2015 Apr; 67(4):637-45. PubMed ID: 25454617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.
    Schröder FH; van der Maas P; Beemsterboer P; Kruger AB; Hoedemaeker R; Rietbergen J; Kranse R
    J Natl Cancer Inst; 1998 Dec; 90(23):1817-23. PubMed ID: 9839522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of screening for breast cancer in high-risk women on health-related quality of life.
    Rijnsburger AJ; Essink-Bot ML; van Dooren S; Borsboom GJ; Seynaeve C; Bartels CC; Klijn JG; Tibben A; de Koning HJ
    Br J Cancer; 2004 Jul; 91(1):69-76. PubMed ID: 15199386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of life and trial adherence among participants in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Taylor KL; Shelby R; Gelmann E; McGuire C
    J Natl Cancer Inst; 2004 Jul; 96(14):1083-94. PubMed ID: 15265970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. False-positive cancer screens and health-related quality of life.
    McGovern PM; Gross CR; Krueger RA; Engelhard DA; Cordes JE; Church TR
    Cancer Nurs; 2004; 27(5):347-52. PubMed ID: 15525861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health literacy and the health status of men with prostate cancer.
    Goodwin BC; March S; Zajdlewicz L; Osborne RH; Dunn J; Chambers SK
    Psychooncology; 2018 Oct; 27(10):2374-2381. PubMed ID: 29959807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality of life in prostate cancer patients taking androgen deprivation therapy.
    Dacal K; Sereika SM; Greenspan SL
    J Am Geriatr Soc; 2006 Jan; 54(1):85-90. PubMed ID: 16420202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. International evaluation of the psychometrics of health-related quality of life questionnaires for use among long-term survivors of testicular and prostate cancer.
    van Leeuwen M; Kieffer JM; Efficace F; Fosså SD; Bolla M; Collette L; Colombel M; De Giorgi U; Holzner B; van de Poll-Franse LV; van Poppel H; White J; de Wit R; Osanto S; Aaronson NK; ; ;
    Health Qual Life Outcomes; 2017 May; 15(1):97. PubMed ID: 28490338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anxiety associated with prostate cancer screening with special reference to men with a positive screening test (elevated PSA) - Results from a prospective, population-based, randomised study.
    Carlsson S; Aus G; Wessman C; Hugosson J
    Eur J Cancer; 2007 Sep; 43(14):2109-16. PubMed ID: 17643983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anxiety in the management of localised prostate cancer by active surveillance.
    Anderson J; Burney S; Brooker JE; Ricciardelli LA; Fletcher JM; Satasivam P; Frydenberg M
    BJU Int; 2014 Nov; 114 Suppl 1():55-61. PubMed ID: 25070423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Having a Pap smear, quality of life before and after cervical screening: a questionnaire study.
    Korfage IJ; van Ballegooijen M; Wauben B; Looman CW; Habbema JD; Essink-Bot ML
    BJOG; 2012 Jul; 119(8):936-44. PubMed ID: 22568482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health-related quality of life in the Finnish trial of screening for prostate cancer.
    Booth N; Rissanen P; Tammela TL; Määttänen L; Taari K; Auvinen A
    Eur Urol; 2014 Jan; 65(1):39-47. PubMed ID: 23265387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON).
    van den Bergh KA; Essink-Bot ML; Borsboom GJ; Th Scholten E; Prokop M; de Koning HJ; van Klaveren RJ
    Br J Cancer; 2010 Jan; 102(1):27-34. PubMed ID: 19935789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dimensions of quality of life expressed by men treated for metastatic prostate cancer.
    Clark JA; Wray N; Brody B; Ashton C; Giesler B; Watkins H
    Soc Sci Med; 1997 Oct; 45(8):1299-309. PubMed ID: 9381242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in health-related quality of life of prostate cancer patients based on stage of cancer.
    Rosenfeld B; Roth AJ; Gandhi S; Penson D
    Psychooncology; 2004 Nov; 13(11):800-7. PubMed ID: 15386638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anxiety and borderline PAP smear results.
    Korfage IJ; van Ballegooijen M; Huveneers H; Essink-Bot ML
    Eur J Cancer; 2010 Jan; 46(1):134-41. PubMed ID: 19683428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.